No Data
Modalis Therapeutics Reports Reduced Losses Due to Lower R&D Expenses
Modalis Therapeutics Reports Foreign Exchange Gains
Modalis Therapeutics Reports Reduced Losses in 2024 Financial Results
Modalis Therapeutics: Summary of Financial Results for the Fiscal Year Ending 2024/12 [Japanese GAAP] (Consolidated)
Modalis Therapeutics: Notice regarding differences between consolidated financial results for the previous fiscal year and the prior period actual values for individual results
Modalis Therapeutics: Presentation of year-end financial results for the fiscal year ending 2024/12